Clinical Practice Guideline

Updated ESMO Clinical Practice Guideline Recommendations in the Non-oncogene-addicted Metastatic NSCLC

ESMO  (European Society for Medical Oncology) shared a post on LinkedIn:

“Updated ESMO Clinical Practice Guideline recommendations in the non-oncogene-addicted metastatic NSCLC: new 1L Treatment options approved.”

Read Full Guidline.

Read OncoDaily’s Special Article: “Metastatic Lung Cancer: Causes, Symptoms, Treatment, and 2025 Advances in Therapy“

Updated ESMO Clinical Practice Guideline Recommendations in the Non-oncogene-addicted Metastatic NSCLC

cancer ESMO ESMO Clinical Practice Guideline metastatic NSCLC Non-oncogene-addicted Metastatic NSCLC OncoDaily Oncology